Pharmacy

Cadila Healthcare, Ars. Rs. 4450 crore plus pharma major from Ahmadabad, has recorded impressive  Financia share performance during the year ended March 2011, on account of higher formulation export and domestic business, new products launch and strategic pact with Abbott Laboratories. The consolidated net profit has taken a quantum jump of 40.8 percent and touched to Rs. 711 crore from 505 crore in the previous year. Its consolidated net sales moved up by 24.9 percent to Rs. 4,465 crore from Rs. 3,574 crore.

Further, the board of directors has recommended higher equity dividend of 125 percent (Rs. 6.25 Per share of Rs. 5 each) for the year 2010-11 as compared to 100 per cent in the previous year. The earnings per share worked out to Rs. 34.73 as against Rs. 24.67 in the last year.

The company's formulation exports was buoyed by 44 percent growth in sales in the US market and 24 percent growth in the emerging markets.